Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| H. Lee Moffitt Cancer Center and Research Institute | OTHER |
Expanded access of Pemigatinib to treat a single patient with metastatic pancreatic cancer.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pemigatinib | Drug |
|
Inclusion Criteria:
-
Exclusion Criteria:
-
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Dae Won Kim, MD | H. Lee Moffitt Cancer Center and Research Institute | Principal Investigator |
Not provided
Not provided
| ID | Term |
|---|---|
| C000705477 | pemigatinib |
Not provided
Not provided
Not provided